Ngā hua rapu - Hankin, Amy
- E whakaatu ana i te 1 - 5 hua o te 5
-
1
A phase II study of the PARP Inhibitor, veliparib plus temozolomide in patients with heavily pretreated, metastatic colorectal cancer mā Pishvaian, Michael J., Slack, Rebecca S, Jiang, Wei, He, A. Ruth, Hwang, Jimmy J., Hankin, Amy, Dorsch-Vogel, Karen, Kukadiya, Divyesh, Weiner, Louis M., Marshall, John L, Brody, Jonathan R.
I whakaputaina 2018Text -
2
Clinical and immunologic impact of short-course enzalutamide alone and with immunotherapy in non-metastatic castration sensitive prostate cancer mā Madan, Ravi A, Karzai, Fatima, Donahue, Renee N, Al-Harthy, Munjid, Bilusic, Marijo, Rosner, Inger I, Singh, Harpreet, Arlen, Philip M, Theoret, Marc R, Marté, Jennifer L, Cordes, Lisa, Couvillon, Anna, Hankin, Amy, Williams, Moniquea, Owens, Helen, Lochrin, Sarah E, Chau, Cindy H, Steinberg, Seth, Figg, William Douglas, Dahut, William, Schlom, Jeffrey, Gulley, James L
I whakaputaina 2021Text -
3
Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations mā Karzai, Fatima, VanderWeele, David, Madan, Ravi A., Owens, Helen, Cordes, Lisa M., Hankin, Amy, Couvillon, Anna, Nichols, Erin, Bilusic, Marijo, Beshiri, Michael L., Kelly, Kathleen, Krishnasamy, Venkatesh, Lee, Sunmin, Lee, Min-Jung, Yuno, Akira, Trepel, Jane B., Merino, Maria J., Dittamore, Ryan, Marté, Jennifer, Donahue, Renee N., Schlom, Jeffrey, Killian, Keith J., Meltzer, Paul S., Steinberg, Seth M., Gulley, James L., Lee, Jung-Min, Dahut, William L.
I whakaputaina 2018Text -
4
Sequential Prostate Magnetic Resonance Imaging in Newly Diagnosed High-Risk Prostate Cancer Treated with Neoadjuvant Enzalutamide is predictive of therapeutic response mā Karzai, Fatima, Walker, Stephanie M., Wilkinson, Scott, Madan, Ravi A., Shih, Joanna H., Merino, Maria J., Harmon, Stephanie A., VanderWeele, David J., Cordes, Lisa M., Carrabba, Nicole V., Bright, John R., Terrigino, Nicolas T., Chun, Guinevere, Bilusic, Marijo, Couvillon, Anna, Hankin, Amy, Williams, Monique N., Lis, Rosina T., Ye, Huihui, Choyke, Peter L., Gulley, James L., Sowalsky, Adam G., Turkbey, Baris, Pinto, Peter A., Dahut, William L.
I whakaputaina 2020Text -
5
Cabozantinib plus docetaxel and prednisone in metastatic castration-resistant prostate cancer mā Madan, Ravi A., Karzai, Fatima H., Harthy, Munjid Al, Petrylak, Daniel P., Kim, Joseph W., Arlen, Philip M., Rosner, Inger, Theoret, Marc R., Cordes, Lisa, Bilusic, Marijo, Peer, Cody J., Dawson, Nancy A., Couvillon, Anna, Hankin, Amy, Williams, Moniquea, Chun, Guin, Owens, Helen, Marte, Jennifer L., Lee, Min-Jung, Tomita, Yusuke, Yuno, Akira, Trepel, Jane B., Lee, Sunmin, Steinberg, Seth M., Gulley, James L., Figg, William D., Dahut, William L.
I whakaputaina 2020Text